statistiche ricercatore

Continente	#
NA - Nord America	1.692
EU - Europa	881
AS - Asia	149
Continente sconosciuto - Info sul continente non disponibili	4
SA - Sud America	2
AF - Africa	1
Totale	2.729

Nazione	#
US - Stati Uniti d'America	1.685
GB - Regno Unito	511
IT - Italia	152
SE - Svezia	64
DE - Germania	49
CN - Cina	44
HK - Hong Kong	30
UA - Ucraina	27
FR - Francia	25
TR - Turchia	24
SG - Singapore	22
BG - Bulgaria	13
FI - Finlandia	11
BE - Belgio	9
CZ - Repubblica Ceca	8
IN - India	7
KR - Corea	7
CA - Canada	6
VN - Vietnam	4
EU - Europa	3
ID - Indonesia	3
IE - Irlanda	3
ES - Italia	2
IR - Iran	2
MN - Mongolia	2
A2 - ???statistics.table.value.countryCode.A2???	1
AE - Emirati Arabi Uniti	1
AL - Albania	1
BR - Brasile	1
CH - Svizzera	1
CL - Cile	1
DO - Repubblica Dominicana	1
EG - Egitto	1
HU - Ungheria	1
JP - Giappone	1
MY - Malesia	1
NL - Olanda	1
PH - Filippine	1
RU - Federazione Russa	1
SK - Slovacchia (Repubblica Slovacca)	1
SM - San Marino	1
Totale	2.729

Nome	#
Seizures of illicit substances for personal use in two Italian provinces: analysis of trends by type and purity from 2008 to 2017	539
Monitoring of adherence to headache treatments by means of hair analysis	295
Tramadol chronic abuse: An evidence from hair analysis by LC tandem MS	284
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study	273
Hair testing in clinical setting: simultaneous determination of 50 psychoactive drugs and metabolites in headache patients by LC tandem MS	236
Development and validation of a liquid chromatography-tandem mass spectrometric assay for quantitative analyses of triptans in hair	213
The role of ethyl glucuronide in supporting medico-legal investigations: Analysis of this biomarker in different postmortem specimens from 21 selected autopsy cases	202
Hair analysis to monitor abuse of analgesic combinations containing butalbital and propyphenazone	200
Diagnostic accuracy of hair analysis for the detection of triptan overuse in migraineurs	187
Intrapatient variability of the hair levels of pain medications in chronic migraine patients - a pilot study	150
Hair testing as a marker of adherence to headache treatments	119
Pharmacokinetics and tolerability of oral cannabis preparations in patients with medication overuse headache (MOH)—a pilot study	101
Totale	2.799

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	668	30	23	29	43	58	89	102	75	91	56	46	26
2020/2021	817	71	65	55	63	64	69	41	83	33	169	69	35
2021/2022	386	40	19	67	22	4	19	12	52	25	30	61	35
2022/2023	309	36	50	25	35	33	42	1	34	26	2	7	18
2023/2024	144	3	10	11	19	27	30	16	10	0	0	4	14
2024/2025	13	13	0	0	0	0	0	0	0	0	0	0	0
Totale													2.799